首页 | 本学科首页   官方微博 | 高级检索  
检索        

静脉用抗菌素对良性气管狭窄呼吸内镜介入治疗术后长期疗效的影响
引用本文:李莉华,黎雨,甘罗曼,徐明鹏,李文涛,侯长春,唐丽安,李丽芳,李娜,柳广南.静脉用抗菌素对良性气管狭窄呼吸内镜介入治疗术后长期疗效的影响[J].国际呼吸杂志,2017,37(15).
作者姓名:李莉华  黎雨  甘罗曼  徐明鹏  李文涛  侯长春  唐丽安  李丽芳  李娜  柳广南
作者单位:1. 广西医科大学第二附属医院呼吸内科,南宁,530007;2. 青海大学,西宁,810016
基金项目:广西自然科学基金(桂科技攻关12300015)Natural Science Foundation of Guangxi
摘    要:目的 探讨良性气管狭窄患者呼吸内镜介入治疗后静脉用抗菌素治疗1个月对长期疗效的影响.方法 回顾性分析从2012年5月至2015年4月因不同病因致良性气管狭窄收住广西医科大学第一附属医院呼吸内科的75例患者的临床资料.按术后接受静脉用抗菌素治疗的时间分组,其中抗菌素治疗时间≤2周为抗菌素短期治疗组(即短期组),抗菌素治疗时间≥1个月为抗菌素持续治疗组(即持续组),同时所有患者住院期间及出院后均雾化吸入阿米卡星和布地奈德悬液治疗共计6个月.近期及6个月后分析2组患者的治疗效果和并发症.结果 经呼吸内镜介入治疗后,短期组狭窄段气管内径由(3.81±0.80) mm增加到(12.55±1.25) mm(t=-46.41,P<0.05),持续组狭窄段气管内径由(3.78±0.66) mm增加到(12.35±1.43) mm (t =-50.60,P<0.05),差异均有统计学意义;短期组气促评分由3.41±0.78降低到0.55±0.63(t=19.53,P<0.05),持续组气促评分由3.43±0.66降低到0.54±0.51 (t =3.43,P<0.05),差异均有统计学意义.术后近期治疗效果均为100.00%,持续组6个月的总体有效率显著高于短期组(93.48% vs 44.83%,x2=22.26,P<0.05).2组均未出现二重感染等抗菌素治疗的并发症.结论 良性气管狭窄者介入术后较长时间应用抗菌素可明显减少再狭窄率,提高长期疗效.

关 键 词:良性气管狭窄  呼吸内镜  介入治疗  抗菌素  术后处理

Management of post bronchoscopic interventional therapy for patients with benign tracheal stenosis:effect of long-term intravenous antibiotics use
Li Lihua,Li Yu,Gan Luoman,Xu Mingpeng,Li Wentao,Hou Changchun,Tang Lian,Li Lifang,Li Na,Liu Guangnan.Management of post bronchoscopic interventional therapy for patients with benign tracheal stenosis:effect of long-term intravenous antibiotics use[J].International Journal of Respiration,2017,37(15).
Authors:Li Lihua  Li Yu  Gan Luoman  Xu Mingpeng  Li Wentao  Hou Changchun  Tang Lian  Li Lifang  Li Na  Liu Guangnan
Abstract:Objective To evaluate the efficacy of long-term intravenous antibiotics in the treatment of patients with benign tracheal stenosis after bronchoscopic interventional therapy.Methods Seventy-five patients with benign tracheal stenosis were divided into short-term group and long-term group according to the duration of intravenous antibiotics after bronchoscopic interventional therapy.Patients in short-term group were treated with intravenous antibiotics for less than two weeks.Patients in long-term group were treated with intravenous antibiotics for more than one month.And they also treated with inhalation of amikacin and budesonide suspension for six months during hospitalization and after discharge.The treatment efficacy and complications were evaluated after six months.Results In short-term group,the tracheal diameter increased from (3.81 ±0.80) mm to (12.55t1.25) mm (t =-46.41,P<0.05),the dyspnea index decreased from 3.41±0.78 to 0.55±0.63 (t =19.53,P <0.05).In long-term group,the tracheal diameter increased from (3.78±0.66) mm to (12.35±1.43) mm (t =-50.60,P <0.05),the dyspnea index decreased from 3.43±0.66 to 0.54 ± 0.51 (t =3.43,P < 0.05).The immediate efficacy all reached 100.00% in both two groups.In six months,the overall effective rate in long-term group was higher than that in short-term group (93.48% vs 44.83%,x2 =22.26,P <0.05).There was no complications happened in both two groups.Conclusions Long-term intravenous antibiotic therapy in patients with benign tracheal stenosis after bronchoscopic interventional therapy can reduce the restenosis rate significantly and improve the long-term efficacy.
Keywords:Benign tracheal stenosis  Respiratory endoscopy  Interventional therapy  Antibiotics  Postoperative management
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号